School of Sports and Health, Nanjing Sport Institute, 8 Linggusi Road, Nanjing, PA 210014, China.
Department of Science and Technology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, PA 210006, China.
Int Health. 2021 Sep 3;13(5):471-479. doi: 10.1093/inthealth/ihaa089.
Resistance training with blood flow restriction (BFR) is a physiological ischaemic training method. Before it is applied to patients with coronary artery disease, it must be proven safe and effective.
Twenty-four healthy adult males were randomly assigned to three groups: the resistance training (RT) group, low-pressure BFR and resistance training (LP-RT) group and high-pressure BFR and resistance training (HP-RT) group. The training protocol was 20 times/min/set, with a 2-min break, five sets/day and 5 d/week for 8 weeks. Cardiac function, haemodynamics and vascular endothelial function were evaluated before and after the first training and the last training.
There were no significant differences among groups before and after training. After 8 weeks of training, the resting heart rate (p<0.05) of the three groups significantly decreased (p<0.05). The rate-pressure product in the LP-RT group significantly decreased (p<0.05) compared with before training. Just after the last training, heart rate (p<0.05) and cardiac output (p<0.05) in the LP-RT and HP-RT groups significantly decreased compared with those just after the first training. At the end of the experiment, vascular endothelial growth factor (VEGF; p<0.01), soluble VEGF receptor (VEGFR) (p<0.05) and interleukin-6 (p<0.01) significantly increased, except for soluble VEGFR in the RT group.
Low-intensity resistance training with BFR moderately alters cardiac function. The expression levels of proteins related to vascular endothelial function have significantly changed. Both findings suggest that low-intensity resistance training with BFR may be safely and effectively applied to patients with coronary artery disease.
血流限制阻力训练(BFR)是一种生理性缺血训练方法。在将其应用于冠心病患者之前,必须证明其是安全有效的。
24 名健康成年男性被随机分为三组:阻力训练(RT)组、低压力 BFR 和阻力训练(LP-RT)组和高压力 BFR 和阻力训练(HP-RT)组。训练方案为 20 次/分钟/组,每组之间休息 2 分钟,每天 5 组,每周 5 天,共 8 周。在第一次训练和最后一次训练前后评估心脏功能、血液动力学和血管内皮功能。
训练前后三组之间无显著差异。经过 8 周的训练,三组的静息心率(p<0.05)均显著降低(p<0.05)。LP-RT 组的心率-血压乘积显著降低(p<0.05),与训练前相比。最后一次训练后,LP-RT 和 HP-RT 组的心率(p<0.05)和心输出量(p<0.05)均显著低于第一次训练后。实验结束时,血管内皮生长因子(VEGF;p<0.01)、可溶性血管内皮生长因子受体(VEGFR)(p<0.05)和白细胞介素-6(IL-6;p<0.01)显著升高,RT 组除外可溶性 VEGFR。
低强度 BFR 阻力训练适度改变心脏功能。与血管内皮功能相关的蛋白表达水平发生了显著变化。这两个发现表明,低强度 BFR 阻力训练可能安全有效地应用于冠心病患者。